Global Multiple Sclerosis (MS) Drugs Industry Research Report 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The Multiple Sclerosis (MS) Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Multiple Sclerosis (MS) Drugs is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Multiple Sclerosis (MS) Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Multiple Sclerosis (MS) Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Multiple Sclerosis (MS) Drugs market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The Multiple Sclerosis (MS) Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Multiple Sclerosis (MS) Drugs is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Multiple Sclerosis (MS) Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Multiple Sclerosis (MS) Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Multiple Sclerosis (MS) Drugs market are discussed.
The market is segmented by types:
- Copaxone (Glatiramer Acetate, Copolymer 1)
- Novantrone (Mitoxantrone)
- Gilenya (Fingolimod, Fty720)
- Aubagio (Teriflunomide)
- Tecfidera (Dimethyl Fumarate)
- Firategrast (Sb683699, T-0047)
- Siponimod (Baf312)
- Others
- RRMS
- SPMS
- PPMS
- PRMS
Finally, the report provides detailed profile and data information analysis of leading company.
- Bayer AG
- Antisense Therapeutics
- Cinnagen
- Bayhill Therapeutics
- Fast Forward Llc
- Biogen Idec
- Five Prime Therapeutics
- Eli Lilly
- Daiichi Sankyo
- Apitope
- Gw Pharmaceuticals
- Genmab
- Innate Immunotherapeutics
- Glaxosmithkline
- Artielle Immunotherapeutics
- Genzyme
- xx data tables and xx additional tables
- An overview of global Multiple Sclerosis (MS) Drugs market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Multiple Sclerosis (MS) Drugs market
- Profiles of major players in the industry, including Bayer AG, Antisense Therapeutics, Cinnagen, Bayhill Therapeutics, Fast Forward Llc.....
- To study and analyze the global Multiple Sclerosis (MS) Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Multiple Sclerosis (MS) Drugs market by identifying its various subsegments.
- Focuses on the key global Multiple Sclerosis (MS) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the Multiple Sclerosis (MS) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Multiple Sclerosis (MS) Drugs submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Multiple Sclerosis (MS) Drugs Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 Multiple Sclerosis (MS) Drugs Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 MULTIPLE SCLEROSIS (MS) DRUGS INDUSTRY OVERVIEW
2.1 Global Multiple Sclerosis (MS) Drugs Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Multiple Sclerosis (MS) Drugs Global Import Market Analysis
2.1.2 Multiple Sclerosis (MS) Drugs Global Export Market Analysis
2.1.3 Multiple Sclerosis (MS) Drugs Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Copaxone (Glatiramer Acetate, Copolymer 1)
2.2.2 Novantrone (Mitoxantrone)
2.2.3 Gilenya (Fingolimod, Fty720)
2.2.4 Aubagio (Teriflunomide)
2.2.5 Tecfidera (Dimethyl Fumarate)
2.2.6 Firategrast (Sb683699, T-0047)
2.2.7 Siponimod (Baf312)
2.2.8 Others
2.3 Market Analysis by Application
2.3.1 RRMS
2.3.2 SPMS
2.3.3 PPMS
2.3.4 PRMS
2.4 Global Multiple Sclerosis (MS) Drugs Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Multiple Sclerosis (MS) Drugs Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Multiple Sclerosis (MS) Drugs Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Multiple Sclerosis (MS) Drugs Manufacturer Market Share
2.4.5 Top 10 Multiple Sclerosis (MS) Drugs Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Multiple Sclerosis (MS) Drugs Market
2.4.7 Key Manufacturers Multiple Sclerosis (MS) Drugs Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Multiple Sclerosis (MS) Drugs Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Multiple Sclerosis (MS) Drugs Industry Impact
2.7.1 How the Covid-19 is Affecting the Multiple Sclerosis (MS) Drugs Industry
2.7.2 Multiple Sclerosis (MS) Drugs Business Impact Assessment - Covid-19
2.7.3 Market Trends and Multiple Sclerosis (MS) Drugs Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Multiple Sclerosis (MS) Drugs Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region
4.2 Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2015-2019)
4.3 Global Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Multiple Sclerosis (MS) Drugs Market Size Detail
4.4.1 North America Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.4.2 North America Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Multiple Sclerosis (MS) Drugs Market Size Detail
4.5.1 Europe Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.5.2 Europe Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Multiple Sclerosis (MS) Drugs Market Size Detail
4.6.1 Japan Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.6.2 Japan Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Multiple Sclerosis (MS) Drugs Market Size Detail
4.7.1 China Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.7.2 China Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET SEGMENT BY TYPE
5.1 Global Multiple Sclerosis (MS) Drugs Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share by Type (2015-2020)
5.1.2 Global Multiple Sclerosis (MS) Drugs Revenue and Market Share by Type (2015-2020)
5.2 Copaxone (Glatiramer Acetate, Copolymer 1) Sales Growth Rate and Price
5.2.1 Global Copaxone (Glatiramer Acetate, Copolymer 1) Sales Growth Rate (2015-2020)
5.2.2 Global Copaxone (Glatiramer Acetate, Copolymer 1) Price (2015-2020)
5.3 Novantrone (Mitoxantrone) Sales Growth Rate and Price
5.3.1 Global Novantrone (Mitoxantrone) Sales Growth Rate (2015-2020)
5.3.2 Global Novantrone (Mitoxantrone) Price (2015-2020)
5.4 Gilenya (Fingolimod, Fty720) Sales Growth Rate and Price
5.4.1 Global Gilenya (Fingolimod, Fty720) Sales Growth Rate (2015-2020)
5.4.2 Global Gilenya (Fingolimod, Fty720) Price (2015-2020)
5.5 Aubagio (Teriflunomide) Sales Growth Rate and Price
5.5.1 Global Aubagio (Teriflunomide) Sales Growth Rate (2015-2020)
5.5.2 Global Aubagio (Teriflunomide) Price (2015-2020)
5.6 Tecfidera (Dimethyl Fumarate) Sales Growth Rate and Price
5.6.1 Global Tecfidera (Dimethyl Fumarate) Sales Growth Rate (2015-2020)
5.6.2 Global Tecfidera (Dimethyl Fumarate) Price (2015-2020)
5.7 Firategrast (Sb683699, T-0047) Sales Growth Rate and Price
5.7.1 Global Firategrast (Sb683699, T-0047) Sales Growth Rate (2015-2020)
5.7.2 Global Firategrast (Sb683699, T-0047) Price (2015-2020)
5.8 Siponimod (Baf312) Sales Growth Rate and Price
5.8.1 Global Siponimod (Baf312) Sales Growth Rate (2015-2020)
5.8.2 Global Siponimod (Baf312) Price (2015-2020)
5.9 Others Sales Growth Rate and Price
5.9.1 Global Others Sales Growth Rate (2015-2020)
5.9.2 Global Others Price (2015-2020)
6 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET SEGMENT BY APPLICATION
6.1 Global Multiple Sclerosis (MS) DrugsSales Market Share by Application (2015-2020)
6.2 RRMS Sales Growth Rate (2015-2020)
6.3 SPMS Sales Growth Rate (2015-2020)
6.4 PPMS Sales Growth Rate (2015-2020)
6.5 PRMS Sales Growth Rate (2015-2020)
7 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET FORECAST
7.1 Global Multiple Sclerosis (MS) Drugs Sales, Revenue Forecast
7.1.1 Global Multiple Sclerosis (MS) Drugs Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Multiple Sclerosis (MS) Drugs Price and Trend Forecast (2020-2025)
7.2 Global Multiple Sclerosis (MS) Drugs Sales Forecast by Region (2020-2025)
7.2.1 North America Multiple Sclerosis (MS) Drugs Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Multiple Sclerosis (MS) Drugs Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Multiple Sclerosis (MS) Drugs Production, Revenue Forecast (2020-2025)
7.2.4 China Multiple Sclerosis (MS) Drugs Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF MULTIPLE SCLEROSIS (MS) DRUGS INDUSTRY KEY MANUFACTURERS
8.1 Bayer AG
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Bayer AG Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Bayer AG News
8.2 Antisense Therapeutics
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Antisense Therapeutics News
8.3 Cinnagen
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Cinnagen Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Cinnagen News
8.4 Bayhill Therapeutics
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Bayhill Therapeutics News
8.5 Fast Forward Llc
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Fast Forward Llc Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Fast Forward Llc News
8.6 Biogen Idec
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Biogen Idec Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Biogen Idec News
8.7 Five Prime Therapeutics
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Five Prime Therapeutics News
8.8 Eli Lilly
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Eli Lilly Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Eli Lilly News
8.9 Daiichi Sankyo
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Daiichi Sankyo News
8.10 Apitope
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Apitope Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Apitope News
8.11 Gw Pharmaceuticals
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Gw Pharmaceuticals News
8.12 Genmab
8.12.1 Company Details
8.12.2 Product Information
8.12.3 Genmab Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 Genmab News
8.13 Innate Immunotherapeutics
8.13.1 Company Details
8.13.2 Product Information
8.13.3 Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 Innate Immunotherapeutics News
8.14 Glaxosmithkline
8.14.1 Company Details
8.14.2 Product Information
8.14.3 Glaxosmithkline Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.14.4 Main Business Overview
8.14.5 Glaxosmithkline News
8.15 Artielle Immunotherapeutics
8.15.1 Company Details
8.15.2 Product Information
8.15.3 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.15.4 Main Business Overview
8.15.5 Artielle Immunotherapeutics News
8.16 Genzyme
8.16.1 Company Details
8.16.2 Product Information
8.16.3 Genzyme Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.16.4 Main Business Overview
8.16.5 Genzyme News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
1 SCOPE OF THE STUDY
1.1 Multiple Sclerosis (MS) Drugs Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 MULTIPLE SCLEROSIS (MS) DRUGS INDUSTRY OVERVIEW
2.1 Global Multiple Sclerosis (MS) Drugs Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Multiple Sclerosis (MS) Drugs Global Import Market Analysis
2.1.2 Multiple Sclerosis (MS) Drugs Global Export Market Analysis
2.1.3 Multiple Sclerosis (MS) Drugs Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Copaxone (Glatiramer Acetate, Copolymer 1)
2.2.2 Novantrone (Mitoxantrone)
2.2.3 Gilenya (Fingolimod, Fty720)
2.2.4 Aubagio (Teriflunomide)
2.2.5 Tecfidera (Dimethyl Fumarate)
2.2.6 Firategrast (Sb683699, T-0047)
2.2.7 Siponimod (Baf312)
2.2.8 Others
2.3 Market Analysis by Application
2.3.1 RRMS
2.3.2 SPMS
2.3.3 PPMS
2.3.4 PRMS
2.4 Global Multiple Sclerosis (MS) Drugs Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Multiple Sclerosis (MS) Drugs Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Multiple Sclerosis (MS) Drugs Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Multiple Sclerosis (MS) Drugs Manufacturer Market Share
2.4.5 Top 10 Multiple Sclerosis (MS) Drugs Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Multiple Sclerosis (MS) Drugs Market
2.4.7 Key Manufacturers Multiple Sclerosis (MS) Drugs Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Multiple Sclerosis (MS) Drugs Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Multiple Sclerosis (MS) Drugs Industry Impact
2.7.1 How the Covid-19 is Affecting the Multiple Sclerosis (MS) Drugs Industry
2.7.2 Multiple Sclerosis (MS) Drugs Business Impact Assessment - Covid-19
2.7.3 Market Trends and Multiple Sclerosis (MS) Drugs Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Multiple Sclerosis (MS) Drugs Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)
4.1 Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region
4.2 Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2015-2019)
4.3 Global Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Multiple Sclerosis (MS) Drugs Market Size Detail
4.4.1 North America Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.4.2 North America Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Multiple Sclerosis (MS) Drugs Market Size Detail
4.5.1 Europe Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.5.2 Europe Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Multiple Sclerosis (MS) Drugs Market Size Detail
4.6.1 Japan Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.6.2 Japan Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Multiple Sclerosis (MS) Drugs Market Size Detail
4.7.1 China Multiple Sclerosis (MS) Drugs Sales Growth Rate (2015-2020)
4.7.2 China Multiple Sclerosis (MS) Drugs Sales, Revenue, Price and Gross Margin (2015-2020)
5 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET SEGMENT BY TYPE
5.1 Global Multiple Sclerosis (MS) Drugs Revenue, Sales and Market Share by Type (2015-2020)
5.1.1 Global Multiple Sclerosis (MS) Drugs Sales and Market Share by Type (2015-2020)
5.1.2 Global Multiple Sclerosis (MS) Drugs Revenue and Market Share by Type (2015-2020)
5.2 Copaxone (Glatiramer Acetate, Copolymer 1) Sales Growth Rate and Price
5.2.1 Global Copaxone (Glatiramer Acetate, Copolymer 1) Sales Growth Rate (2015-2020)
5.2.2 Global Copaxone (Glatiramer Acetate, Copolymer 1) Price (2015-2020)
5.3 Novantrone (Mitoxantrone) Sales Growth Rate and Price
5.3.1 Global Novantrone (Mitoxantrone) Sales Growth Rate (2015-2020)
5.3.2 Global Novantrone (Mitoxantrone) Price (2015-2020)
5.4 Gilenya (Fingolimod, Fty720) Sales Growth Rate and Price
5.4.1 Global Gilenya (Fingolimod, Fty720) Sales Growth Rate (2015-2020)
5.4.2 Global Gilenya (Fingolimod, Fty720) Price (2015-2020)
5.5 Aubagio (Teriflunomide) Sales Growth Rate and Price
5.5.1 Global Aubagio (Teriflunomide) Sales Growth Rate (2015-2020)
5.5.2 Global Aubagio (Teriflunomide) Price (2015-2020)
5.6 Tecfidera (Dimethyl Fumarate) Sales Growth Rate and Price
5.6.1 Global Tecfidera (Dimethyl Fumarate) Sales Growth Rate (2015-2020)
5.6.2 Global Tecfidera (Dimethyl Fumarate) Price (2015-2020)
5.7 Firategrast (Sb683699, T-0047) Sales Growth Rate and Price
5.7.1 Global Firategrast (Sb683699, T-0047) Sales Growth Rate (2015-2020)
5.7.2 Global Firategrast (Sb683699, T-0047) Price (2015-2020)
5.8 Siponimod (Baf312) Sales Growth Rate and Price
5.8.1 Global Siponimod (Baf312) Sales Growth Rate (2015-2020)
5.8.2 Global Siponimod (Baf312) Price (2015-2020)
5.9 Others Sales Growth Rate and Price
5.9.1 Global Others Sales Growth Rate (2015-2020)
5.9.2 Global Others Price (2015-2020)
6 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET SEGMENT BY APPLICATION
6.1 Global Multiple Sclerosis (MS) DrugsSales Market Share by Application (2015-2020)
6.2 RRMS Sales Growth Rate (2015-2020)
6.3 SPMS Sales Growth Rate (2015-2020)
6.4 PPMS Sales Growth Rate (2015-2020)
6.5 PRMS Sales Growth Rate (2015-2020)
7 GLOBAL MULTIPLE SCLEROSIS (MS) DRUGS MARKET FORECAST
7.1 Global Multiple Sclerosis (MS) Drugs Sales, Revenue Forecast
7.1.1 Global Multiple Sclerosis (MS) Drugs Sales Growth Rate Forecast (2020-2025)
7.1.2 Global Multiple Sclerosis (MS) Drugs Revenue and Growth Rate Forecast (2020-2025)
7.1.3 Global Multiple Sclerosis (MS) Drugs Price and Trend Forecast (2020-2025)
7.2 Global Multiple Sclerosis (MS) Drugs Sales Forecast by Region (2020-2025)
7.2.1 North America Multiple Sclerosis (MS) Drugs Sales, Revenue Forecast (2020-2025)
7.2.2 Europe Multiple Sclerosis (MS) Drugs Sales, Revenue Forecast (2020-2025)
7.2.3 Japan Multiple Sclerosis (MS) Drugs Production, Revenue Forecast (2020-2025)
7.2.4 China Multiple Sclerosis (MS) Drugs Production, Revenue Forecast (2020-2025)
8 ANALYSIS OF MULTIPLE SCLEROSIS (MS) DRUGS INDUSTRY KEY MANUFACTURERS
8.1 Bayer AG
8.1.1 Company Details
8.1.2 Product Information
8.1.3 Bayer AG Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.1.4 Main Business Overview
8.1.5 Bayer AG News
8.2 Antisense Therapeutics
8.2.1 Company Details
8.2.2 Product Information
8.2.3 Antisense Therapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.2.4 Main Business Overview
8.2.5 Antisense Therapeutics News
8.3 Cinnagen
8.3.1 Company Details
8.3.2 Product Information
8.3.3 Cinnagen Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.3.4 Main Business Overview
8.3.5 Cinnagen News
8.4 Bayhill Therapeutics
8.4.1 Company Details
8.4.2 Product Information
8.4.3 Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.4.4 Main Business Overview
8.4.5 Bayhill Therapeutics News
8.5 Fast Forward Llc
8.5.1 Company Details
8.5.2 Product Information
8.5.3 Fast Forward Llc Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.5.4 Main Business Overview
8.5.5 Fast Forward Llc News
8.6 Biogen Idec
8.6.1 Company Details
8.6.2 Product Information
8.6.3 Biogen Idec Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.6.4 Main Business Overview
8.6.5 Biogen Idec News
8.7 Five Prime Therapeutics
8.7.1 Company Details
8.7.2 Product Information
8.7.3 Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.7.4 Main Business Overview
8.7.5 Five Prime Therapeutics News
8.8 Eli Lilly
8.8.1 Company Details
8.8.2 Product Information
8.8.3 Eli Lilly Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.8.4 Main Business Overview
8.8.5 Eli Lilly News
8.9 Daiichi Sankyo
8.9.1 Company Details
8.9.2 Product Information
8.9.3 Daiichi Sankyo Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.9.4 Main Business Overview
8.9.5 Daiichi Sankyo News
8.10 Apitope
8.10.1 Company Details
8.10.2 Product Information
8.10.3 Apitope Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.10.4 Main Business Overview
8.10.5 Apitope News
8.11 Gw Pharmaceuticals
8.11.1 Company Details
8.11.2 Product Information
8.11.3 Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.11.4 Main Business Overview
8.11.5 Gw Pharmaceuticals News
8.12 Genmab
8.12.1 Company Details
8.12.2 Product Information
8.12.3 Genmab Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.12.4 Main Business Overview
8.12.5 Genmab News
8.13 Innate Immunotherapeutics
8.13.1 Company Details
8.13.2 Product Information
8.13.3 Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.13.4 Main Business Overview
8.13.5 Innate Immunotherapeutics News
8.14 Glaxosmithkline
8.14.1 Company Details
8.14.2 Product Information
8.14.3 Glaxosmithkline Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.14.4 Main Business Overview
8.14.5 Glaxosmithkline News
8.15 Artielle Immunotherapeutics
8.15.1 Company Details
8.15.2 Product Information
8.15.3 Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.15.4 Main Business Overview
8.15.5 Artielle Immunotherapeutics News
8.16 Genzyme
8.16.1 Company Details
8.16.2 Product Information
8.16.3 Genzyme Multiple Sclerosis (MS) Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
8.16.4 Main Business Overview
8.16.5 Genzyme News
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
LIST OF TABLES AND FIGURES
Figure Multiple Sclerosis (MS) Drugs Picture
Figure Research Programs/Design for This Report
Figure Global Multiple Sclerosis (MS) Drugs Market by Regions (2019)
Table Global Market Multiple Sclerosis (MS) Drugs Comparison by Regions (M USD) 2019-2025
Table Global Multiple Sclerosis (MS) Drugs Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Multiple Sclerosis (MS) Drugs by Type in 2019
Figure Copaxone (Glatiramer Acetate, Copolymer 1) Picture
Figure Novantrone (Mitoxantrone) Picture
Figure Gilenya (Fingolimod, Fty720) Picture
Figure Aubagio (Teriflunomide) Picture
Figure Tecfidera (Dimethyl Fumarate) Picture
Figure Firategrast (Sb683699, T-0047) Picture
Figure Siponimod (Baf312) Picture
Figure Others Picture
Table Global Multiple Sclerosis (MS) Drugs Sales by Application (2019-2025)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application in 2019
Figure RRMS Picture
Figure SPMS Picture
Figure PPMS Picture
Figure PRMS Picture
Table Global Multiple Sclerosis (MS) Drugs Sales by Manufacturer (2018-2020)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Manufacturer in 2019
Table Global Multiple Sclerosis (MS) Drugs Revenue by Manufacturer (2018-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Manufacturer in 2019
Table Global Multiple Sclerosis (MS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Multiple Sclerosis (MS) Drugs Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Multiple Sclerosis (MS) Drugs Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Multiple Sclerosis (MS) Drugs Market
Table Key Manufacturers Multiple Sclerosis (MS) Drugs Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis (MS) Drugs
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Multiple Sclerosis (MS) Drugs Sales (K Units) by Region (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2015-2019)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2015-2019)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region in 2018
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million US$) by Region (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region in 2019
Table Global Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table North America Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table Europe Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table Japan Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table China Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales by Type (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Type in 2019
Table Global Multiple Sclerosis (MS) Drugs Revenue by Type (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Type (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Type in 2019
Figure Global Copaxone (Glatiramer Acetate, Copolymer 1) Sales Growth Rate (2015-2020)
Figure Global Copaxone (Glatiramer Acetate, Copolymer 1) Price (2015-2020)
Figure Global Novantrone (Mitoxantrone) Sales Growth Rate (2015-2020)
Figure Global Novantrone (Mitoxantrone) Price (2015-2020)
Figure Global Gilenya (Fingolimod, Fty720) Sales Growth Rate (2015-2020)
Figure Global Gilenya (Fingolimod, Fty720) Price (2015-2020)
Figure Global Aubagio (Teriflunomide) Sales Growth Rate (2015-2020)
Figure Global Aubagio (Teriflunomide) Price (2015-2020)
Figure Global Tecfidera (Dimethyl Fumarate) Sales Growth Rate (2015-2020)
Figure Global Tecfidera (Dimethyl Fumarate) Price (2015-2020)
Figure Global Firategrast (Sb683699, T-0047) Sales Growth Rate (2015-2020)
Figure Global Firategrast (Sb683699, T-0047) Price (2015-2020)
Figure Global Siponimod (Baf312) Sales Growth Rate (2015-2020)
Figure Global Siponimod (Baf312) Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales by Application (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application in 2019
Figure Global RRMS Sales Growth Rate (2015-2020)
Figure Global SPMS Sales Growth Rate (2015-2020)
Figure Global PPMS Sales Growth Rate (2015-2020)
Figure Global PRMS Sales Growth Rate (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Multiple Sclerosis (MS) Drugs Price and Trend Forecast (2020-2025)
Table Global Multiple Sclerosis (MS) Drugs Sales (K Units) Forecast by Region (2020-2025)
Figure Global Multiple Sclerosis (MS) Drugs Production Market Share Forecast by Region (2020-2025)
Figure North America Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Multiple Sclerosis (MS) Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Multiple Sclerosis (MS) Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Bayer AG Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Bayer AG
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer AG Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Antisense Therapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Antisense Therapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Antisense Therapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Antisense Therapeutics Main Business
Table Antisense Therapeutics Recent Development
Table Cinnagen Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Cinnagen
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cinnagen Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Cinnagen Main Business
Table Cinnagen Recent Development
Table Bayhill Therapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Bayhill Therapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Bayhill Therapeutics Main Business
Table Bayhill Therapeutics Recent Development
Table Fast Forward Llc Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Fast Forward Llc
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Fast Forward Llc Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Fast Forward Llc Main Business
Table Fast Forward Llc Recent Development
Table Biogen Idec Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Biogen Idec
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biogen Idec Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Biogen Idec Main Business
Table Biogen Idec Recent Development
Table Five Prime Therapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Five Prime Therapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Five Prime Therapeutics Main Business
Table Five Prime Therapeutics Recent Development
Table Eli Lilly Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Eli Lilly
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Daiichi Sankyo Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Daiichi Sankyo
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Daiichi Sankyo Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Apitope Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Apitope
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Apitope Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Apitope Main Business
Table Apitope Recent Development
Table Gw Pharmaceuticals Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Gw Pharmaceuticals
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Gw Pharmaceuticals Main Business
Table Gw Pharmaceuticals Recent Development
Table Genmab Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Genmab
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genmab Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Genmab Main Business
Table Genmab Recent Development
Table Innate Immunotherapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Innate Immunotherapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Innate Immunotherapeutics Main Business
Table Innate Immunotherapeutics Recent Development
Table Glaxosmithkline Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Glaxosmithkline
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Glaxosmithkline Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Glaxosmithkline Main Business
Table Glaxosmithkline Recent Development
Table Artielle Immunotherapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Artielle Immunotherapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Artielle Immunotherapeutics Main Business
Table Artielle Immunotherapeutics Recent Development
Table Genzyme Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Genzyme
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genzyme Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Genzyme Main Business
Table Genzyme Recent Development
Table of Appendix
Figure Multiple Sclerosis (MS) Drugs Picture
Figure Research Programs/Design for This Report
Figure Global Multiple Sclerosis (MS) Drugs Market by Regions (2019)
Table Global Market Multiple Sclerosis (MS) Drugs Comparison by Regions (M USD) 2019-2025
Table Global Multiple Sclerosis (MS) Drugs Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Multiple Sclerosis (MS) Drugs by Type in 2019
Figure Copaxone (Glatiramer Acetate, Copolymer 1) Picture
Figure Novantrone (Mitoxantrone) Picture
Figure Gilenya (Fingolimod, Fty720) Picture
Figure Aubagio (Teriflunomide) Picture
Figure Tecfidera (Dimethyl Fumarate) Picture
Figure Firategrast (Sb683699, T-0047) Picture
Figure Siponimod (Baf312) Picture
Figure Others Picture
Table Global Multiple Sclerosis (MS) Drugs Sales by Application (2019-2025)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application in 2019
Figure RRMS Picture
Figure SPMS Picture
Figure PPMS Picture
Figure PRMS Picture
Table Global Multiple Sclerosis (MS) Drugs Sales by Manufacturer (2018-2020)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Manufacturer in 2019
Table Global Multiple Sclerosis (MS) Drugs Revenue by Manufacturer (2018-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Manufacturer in 2019
Table Global Multiple Sclerosis (MS) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Multiple Sclerosis (MS) Drugs Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Multiple Sclerosis (MS) Drugs Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Multiple Sclerosis (MS) Drugs Market
Table Key Manufacturers Multiple Sclerosis (MS) Drugs Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis (MS) Drugs
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Multiple Sclerosis (MS) Drugs Sales (K Units) by Region (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2015-2019)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region (2015-2019)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Region in 2018
Table Global Multiple Sclerosis (MS) Drugs Revenue (Million US$) by Region (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Region in 2019
Table Global Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table North America Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table Europe Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table Japan Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate (2015-2020)
Table China Multiple Sclerosis (MS) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales by Type (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales Market Share by Type (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Type in 2019
Table Global Multiple Sclerosis (MS) Drugs Revenue by Type (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Type (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Revenue Market Share by Type in 2019
Figure Global Copaxone (Glatiramer Acetate, Copolymer 1) Sales Growth Rate (2015-2020)
Figure Global Copaxone (Glatiramer Acetate, Copolymer 1) Price (2015-2020)
Figure Global Novantrone (Mitoxantrone) Sales Growth Rate (2015-2020)
Figure Global Novantrone (Mitoxantrone) Price (2015-2020)
Figure Global Gilenya (Fingolimod, Fty720) Sales Growth Rate (2015-2020)
Figure Global Gilenya (Fingolimod, Fty720) Price (2015-2020)
Figure Global Aubagio (Teriflunomide) Sales Growth Rate (2015-2020)
Figure Global Aubagio (Teriflunomide) Price (2015-2020)
Figure Global Tecfidera (Dimethyl Fumarate) Sales Growth Rate (2015-2020)
Figure Global Tecfidera (Dimethyl Fumarate) Price (2015-2020)
Figure Global Firategrast (Sb683699, T-0047) Sales Growth Rate (2015-2020)
Figure Global Firategrast (Sb683699, T-0047) Price (2015-2020)
Figure Global Siponimod (Baf312) Sales Growth Rate (2015-2020)
Figure Global Siponimod (Baf312) Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales by Application (2015-2020)
Table Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Sales Market Share by Application in 2019
Figure Global RRMS Sales Growth Rate (2015-2020)
Figure Global SPMS Sales Growth Rate (2015-2020)
Figure Global PPMS Sales Growth Rate (2015-2020)
Figure Global PRMS Sales Growth Rate (2015-2020)
Figure Global Multiple Sclerosis (MS) Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Multiple Sclerosis (MS) Drugs Price and Trend Forecast (2020-2025)
Table Global Multiple Sclerosis (MS) Drugs Sales (K Units) Forecast by Region (2020-2025)
Figure Global Multiple Sclerosis (MS) Drugs Production Market Share Forecast by Region (2020-2025)
Figure North America Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Multiple Sclerosis (MS) Drugs Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Multiple Sclerosis (MS) Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Multiple Sclerosis (MS) Drugs Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Multiple Sclerosis (MS) Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Bayer AG Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Bayer AG
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer AG Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Antisense Therapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Antisense Therapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Antisense Therapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Antisense Therapeutics Main Business
Table Antisense Therapeutics Recent Development
Table Cinnagen Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Cinnagen
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Cinnagen Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Cinnagen Main Business
Table Cinnagen Recent Development
Table Bayhill Therapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Bayhill Therapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayhill Therapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Bayhill Therapeutics Main Business
Table Bayhill Therapeutics Recent Development
Table Fast Forward Llc Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Fast Forward Llc
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Fast Forward Llc Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Fast Forward Llc Main Business
Table Fast Forward Llc Recent Development
Table Biogen Idec Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Biogen Idec
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biogen Idec Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Biogen Idec Main Business
Table Biogen Idec Recent Development
Table Five Prime Therapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Five Prime Therapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Five Prime Therapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Five Prime Therapeutics Main Business
Table Five Prime Therapeutics Recent Development
Table Eli Lilly Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Eli Lilly
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Daiichi Sankyo Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Daiichi Sankyo
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Daiichi Sankyo Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Apitope Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Apitope
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Apitope Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Apitope Main Business
Table Apitope Recent Development
Table Gw Pharmaceuticals Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Gw Pharmaceuticals
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Gw Pharmaceuticals Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Gw Pharmaceuticals Main Business
Table Gw Pharmaceuticals Recent Development
Table Genmab Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Genmab
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genmab Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Genmab Main Business
Table Genmab Recent Development
Table Innate Immunotherapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Innate Immunotherapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Innate Immunotherapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Innate Immunotherapeutics Main Business
Table Innate Immunotherapeutics Recent Development
Table Glaxosmithkline Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Glaxosmithkline
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Glaxosmithkline Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Glaxosmithkline Main Business
Table Glaxosmithkline Recent Development
Table Artielle Immunotherapeutics Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Artielle Immunotherapeutics
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Artielle Immunotherapeutics Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Artielle Immunotherapeutics Main Business
Table Artielle Immunotherapeutics Recent Development
Table Genzyme Company Profile
Figure Multiple Sclerosis (MS) Drugs Product Picture and Specifications of Genzyme
Table Multiple Sclerosis (MS) Drugs Production, Price, Revenue and Gross Margin of 2018-2020
Figure Genzyme Multiple Sclerosis (MS) Drugs Market Share (2018-2020)
Table Genzyme Main Business
Table Genzyme Recent Development
Table of Appendix
